PTO Form 1581 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
78883436 |
LAW OFFICE ASSIGNED |
LAW OFFICE 114 |
MARK SECTION |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
EFFIENT |
OWNER SECTION (current) |
NAME |
Eli Lilly and Company |
STREET |
Lilly Corporate Center |
CITY |
Indianapolis |
STATE |
Indiana |
ZIP/POSTAL CODE |
46285 |
COUNTRY |
United States |
PHONE |
317 651 1346 |
FAX |
317 276 1919 |
OWNER SECTION (proposed) |
NAME |
Eli Lilly and Company |
STREET |
Lilly Corporate Center |
CITY |
Indianapolis |
STATE |
Indiana |
ZIP/POSTAL CODE |
46285 |
COUNTRY |
United States |
PHONE |
317 651 1346 |
FAX |
317 276 1919 |
EMAIL |
XXXX |
ATTORNEY SECTION (current) |
NAME |
Bruce W. Longbottom, Robert E. Lee, Jr., Douglas K. Norman, Lawrence T. Welch |
FIRM NAME |
ELI LILLY AND COMPANY |
STREET |
LILLY CORPORATE CENTER |
CITY |
INDIANAPOLIS |
STATE |
Indiana |
POSTAL CODE |
46285 |
COUNTRY |
United States |
PHONE |
317 651 1346 |
FAX |
317 276 1919 |
EMAIL |
trademarks@lilly.com |
ATTORNEY DOCKET NUMBER |
15564 |
ATTORNEY SECTION (proposed) |
NAME |
Bruce W. Longbottom, Robert E. Lee, Jr., Douglas K. Norman, Lawrence T. Welch |
FIRM NAME |
ELI LILLY AND COMPANY |
STREET |
LILLY CORPORATE CENTER |
CITY |
INDIANAPOLIS |
STATE |
Indiana |
POSTAL CODE |
46285 |
COUNTRY |
United States |
PHONE |
317 651 1346 |
FAX |
317 276 1919 |
EMAIL |
trademarks@lilly.com |
AUTHORIZED TO COMMUNICATE VIA E-MAIL |
Yes |
ATTORNEY DOCKET NUMBER |
15564 |
OTHER APPOINTED ATTORNEY |
Robert E. Lee, Jr., Douglas K. Norman, Lawrence T. Welch |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of blood disorders, cancer, cardiovascular
diseases, central nervous system diseases and disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory
diseases, musculoskeletal diseases and disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and
disorders, reproductive disorders, sexual dysfunction, urological disorders and sleep disorders |
GOODS OR SERVICES DELETED FROM THE APPLICATION OR INCLUDED IN A SEPARATE STATEMENT OF USE AND REQUEST TO DIVIDE |
Pharmaceutical preparations, namely, cancer, central nervous system diseases and disorders, diabetes, diabetic neuropathy, endocrine
disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory diseases, musculoskeletal diseases and disorders, neurodegenerative disorders, neurological
disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, urological disorders and sleep
disorders |
GOODS OR SERVICES FOR WHICH APPLICANT HAS BONA FIDE INTENTION TO USE |
Pharmaceutical preparations for the treatment of cardiovascular diseases and blood disorders |
EXTENSION SECTION |
EXTENSION NUMBER |
3 |
ONGOING EFFORT |
steps to obtain governmental approval |
ALLOWANCE MAIL DATE |
01/09/2007 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT |
150 |
TOTAL AMOUNT |
150 |
SIGNATURE SECTION |
SIGNATURE |
/blongbottom/ |
SIGNATORY'S NAME |
Bruce W. Longbottom |
SIGNATORY'S POSITION |
Associate General Counsel |
DATE SIGNED |
01/30/2008 |
FILING INFORMATION |
SUBMIT DATE |
Wed Jan 30 18:13:05 EST 2008 |
TEAS STAMP |
USPTO/ESU-XX.X.XX.XX-2008
0130181305906457-78883436
-40023998d8ad4b22fee141df
f86ce4e1584-DA-3007-20080
130170327889046 |
PTO Form 1581 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: EFFIENT
SERIAL NUMBER: 78883436
The applicant, Eli Lilly and Company, having an address of Lilly Corporate Center, Indianapolis, Indiana United States 46285, requests a six-month extension of time to file the Statement of Use under
37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 01/09/2007.
For International Class 005:
Current identification: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of blood disorders, cancer, cardiovascular diseases, central nervous system
diseases and disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory diseases, musculoskeletal
diseases and disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive
disorders, sexual dysfunction, urological disorders and sleep disorders
This filing does
NOTcover the following goods or services listed in either the application or Notice of Allowance or as subsequently modified for this specific class; these goods or services
are either being
permanently deleted or included in a separately filed Request to Divide: Pharmaceutical preparations, namely, cancer, central nervous system diseases and disorders, diabetes,
diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory diseases, musculoskeletal diseases and disorders,
neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual
dysfunction, urological disorders and sleep disorders
The applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the following goods or services
listed in the Notice of Allowance or as subsequently modified for this specific class: Pharmaceutical preparations for the treatment of cardiovascular diseases and blood disorders
This is the third extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods and/or services covered by
the extension request: steps to obtain governmental approval
The applicant hereby appoints Bruce W. Longbottom, Robert E. Lee, Jr., Douglas K. Norman, Lawrence T. Welch and Robert E. Lee, Jr., Douglas K. Norman, Lawrence T. Welch of ELI LILLY AND
COMPANY, LILLY CORPORATE CENTER, INDIANAPOLIS, Indiana United States 46285 to submit this Request for Extension of Time to File a Statement of Use on behalf of the applicant. The attorney
docket/reference number is 15564.
A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.
Declaration
The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements
and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own
knowledge are true and that all statements made on information and belief are believed to be true.
Signature: /blongbottom/ Date Signed: 01/30/2008
Signatory's Name: Bruce W. Longbottom
Signatory's Position: Associate General Counsel
Mailing Address:
ELI LILLY AND COMPANY
LILLY CORPORATE CENTER
INDIANAPOLIS, Indiana 46285
Mailing Address:
ELI LILLY AND COMPANY
LILLY CORPORATE CENTER
INDIANAPOLIS, Indiana 46285
RAM Sale Number: 3007
RAM Accounting Date: 01/31/2008
Serial Number: 78883436
Internet Transmission Date: Wed Jan 30 18:13:05 EST 2008
TEAS Stamp: USPTO/ESU-XX.X.XX.XX-2008013018130590645
7-78883436-40023998d8ad4b22fee141dff86ce
4e1584-DA-3007-20080130170327889046